NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
October 22, 2025 — Branded Legacy develops low-cost naloxone spray to combat opioid crisis. New intranasal delivery platform aims to match Narcan performance while improving global accessibility and reducing costs significantly.
October 22, 2025 — Izotropic's IzoView Breast CT technology offers compression-free, high-resolution 3D imaging to improve breast cancer detection, especially for women with dense breast tissue during Breast Cancer Awareness Month.
October 22, 2025 — Strawberry Fields REIT acquires 18th Missouri facility for $5.3M, adding 124 beds to healthcare portfolio. Expansion addresses aging population needs across 10 states.
October 22, 2025 — Soligenix's HyBryte therapy shows promising results for cutaneous T-cell lymphoma treatment in FLASH trials. Learn about this breakthrough non-UV photodynamic therapy and its potential impact.
October 22, 2025 — Lantern Pharma partners with Hoth Therapeutics to deploy AI platform PredictBBB.ai™ for neurological drug development. The technology predicts blood-brain barrier penetration with 94% accuracy.
October 22, 2025 — New research reveals mRNA COVID vaccines may boost cancer immunotherapy effectiveness. European Society for Medical Oncology conference findings show unexpected benefit for cancer treatment.
October 22, 2025 — Izotropic's AI-powered IzoView Breast CT Imaging System featured in NetworkNewsWire editorial, revolutionizing breast cancer detection in $9B medical imaging market with 3D technology.
October 22, 2025 — American Heart Association releases 2025 CPR guidelines with new choking protocols, opioid overdose response, and unified chain of survival for all ages in emergency care.
October 22, 2025 — Stevie Gonzales, a baby with Down Syndrome from Escondido, competes in Baby of the Year to raise awareness and secure medical resources. Vote now to support his journey.
October 22, 2025 — Dr. Robert Rosen named 2025 Castle Connolly Top Doctor for 27th year. International vascular specialist at Lenox Hill treats complex conditions with 70,000+ procedures.
October 22, 2025 — New study reveals touchless faucets can harbor dangerous pathogens like Legionella within 2-4 hours of stagnation. Learn about the critical safety window and temperature risks.
October 22, 2025 — Laonson launches precision pill cutter on Kickstarter with patented center-aligning technology. Handles 5-25mm pills of various shapes using medical-grade stainless steel blade for accurate medication dosing.
October 21, 2025 — Alignment Health Plan partners with Suvida Healthcare to expand bilingual primary care access for Hispanic Medicare Advantage members in Arizona's Pima and Maricopa counties.
October 21, 2025 — Oragenics regains NYSE compliance, secures $16.5M funding to advance ONP-002 concussion treatment through Phase II trials using proprietary intranasal delivery technology.
October 21, 2025 — AI transforms breast cancer detection with advanced 3D imaging from Izotropic and medical tech leaders. New technologies target $9B market to improve accuracy for dense breast tissue.
October 21, 2025 — AI-powered breast cancer detection technologies are revolutionizing diagnostics in a $9B market. Izotropic's IzoView system leads innovation alongside industry giants, promising earlier detection.
October 21, 2025 — Researchers develop nanoparticles to combat inflammation and scarring in alcohol-related liver disease (ARLD), affecting 1.5 billion globally. Breakthrough treatment shows promise for halting disease progression.
October 21, 2025 — Quantum BioPharma announces warrant expiration and confirms CVR distribution date for shareholders. Learn about the $700M litigation and biotech developments.
October 21, 2025 — Oncotelic Therapeutics begins Phase 1 trial for Sapu003 using 20nm nanoparticle technology that achieves 100% bioavailability for breast cancer drug delivery, revolutionizing targeted treatment.
October 21, 2025 — Danaher reports Q3 2025 results with $6.1B revenue, 4.5% growth, and $1.89 adjusted EPS. Strong bioprocessing and Cepheid performance drive earnings beat.